Erratum to: Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1693-2
Abstract: Corrections to the last section (‘‘Survival’’) on page 1582: Line: 7 Word: 3 TARE should be changed to TACE Word: 9 TACE should be changed to TARE Line: 10 Word: 4 TARE should be changed… read more here.
Keywords: line word; difference; tace; tare ... See more keywords
Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome
Sign Up to like & getrecommendations! Published in 2021 at "CardioVascular and Interventional Radiology"
DOI: 10.1007/s00270-021-02777-6
Abstract: To compare transarterial chemoembolization (TACE), transarterial radioembolization using Yttrium-90 (TARE), and transarterial ethanol ablation (TEA) for huge hepatocellular carcinoma (HCC) in treatment responses and long-term survival outcomes. In this retrospective study approved by institutional committee,… read more here.
Keywords: tace; tare; survival; tea ... See more keywords
Transarterial radioembolization vs transarterial chemoembolization with drug-eluting beads for treating hepatocellular carcinoma: a cost-effectiveness analysis in Japanese healthcare system
Sign Up to like & getrecommendations! Published in 2024 at "Japanese Journal of Radiology"
DOI: 10.1007/s11604-024-01640-1
Abstract: Transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma; however, it awaits approval in Japan. This study aimed to simulate the cost-effectiveness of TARE over chemoembolization when TARE is approved in Japan and identify the… read more here.
Keywords: tare; deb tace; analysis; cost effectiveness ... See more keywords
Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-021-02745-z
Abstract: Transarterial radioembolization (TARE) with yttrium-90 (Y90) is a promising alternative strategy to treat liver tumors and liver metastasis from colorectal cancer (CRC), as it selectively delivers radioactive isotopes to the tumor via the hepatic artery,… read more here.
Keywords: tare; transarterial radioembolization; ytrrium transarterial; gastrointestinal malignancies ... See more keywords
Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Surgeons"
DOI: 10.1016/j.jamcollsurg.2019.12.026
Abstract: BACKGROUND Liver-directed hepatic arterial therapies are associated with improved survival and effective symptom control for patients with unresectable neuroendocrine liver metastases (NELM). Whether transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) with yttrium-90 (y-90) are associated… read more here.
Keywords: tace; tare; transarterial chemoembolization; neuroendocrine liver ... See more keywords
Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy.
Sign Up to like & getrecommendations! Published in 2023 at "ACS applied materials & interfaces"
DOI: 10.1021/acsami.2c19829
Abstract: Transarterial radioembolization (TARE) is a local radionuclide therapy and is successfully used in hepatocellular carcinoma (HCC) treatment. Radioactive microspheres have been widely studied for TARE. Preparation of ideal radioactive microspheres is significant for clinical research… read more here.
Keywords: polydopamine coated; tare; therapy; radioembolization ... See more keywords
Transarterial radioembolization with Yttrium-90: current status and future prospects
Sign Up to like & getrecommendations! Published in 2020 at "Gastroenterology Report"
DOI: 10.1093/gastro/goz074
Abstract: In recent years, transarterial radioembolization (TARE) with Yttrium-90 (Y90) has emerged as a technique for treating malignant neoplasms in the liver. Compared with other locoregional therapies, such as transarterial chemoembolization (TACE), patients who underwent TARE… read more here.
Keywords: tare; treatment; transarterial radioembolization; group ... See more keywords
Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation
Sign Up to like & getrecommendations! Published in 2025 at "EJNMMI Research"
DOI: 10.1186/s13550-025-01240-8
Abstract: Relatively high mean absorbed doses to the non-tumorous liver tissue (NTLT) are generally well tolerated in transarterial radioembolisation (TARE), potentially due to a heterogeneous dose distribution. This study investigates the macroscopic and microscopic distribution of… read more here.
Keywords: non tumorous; distribution; liver; tare ... See more keywords
Patterns of care and outcomes of definitive external beam radiotherapy and radioembolization for localized hepatocellular carcinoma: A propensity score-adjusted analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.329
Abstract: 329 Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. Most patients with localized HCC are not surgically operable or transplantation candidates, thus there is an increasing role for nonsurgical locoregional therapies.… read more here.
Keywords: hepatocellular carcinoma; tare; propensity score; propensity ... See more keywords
Optimizing treatment sequencing in hepatocellular carcinoma: Impact of radioembolization timing and immune checkpoint inhibitors on survival outcomes.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e16275
Abstract: e16275 Background: The optimal sequencing of available locoregional therapies and systemic treatments for patients with hepatocellular carcinoma (HCC) remains uncertain. This study compared the impact of transarterial radioembolization (TARE) as a first-line (FL) versus second-line… read more here.
Keywords: treatment; immune checkpoint; group; hepatocellular carcinoma ... See more keywords
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib.
Sign Up to like & getrecommendations! Published in 2018 at "Future oncology"
DOI: 10.2217/fon-2017-0566
Abstract: AIM The aim was to evaluate cost-effectiveness of yttrium-90 transarterial radioembolization (TARE) in comparison to sorafenib treatment. PATIENTS & METHODS A single-center, retrospective, observational study was performed, 166 patients with intermediate-/advanced-stage hepatocellular carcinoma were treated with… read more here.
Keywords: hepatocellular carcinoma; yttrium transarterial; tare; treatment ... See more keywords